Merged Meiji group outlines pharma ambitions
This article was originally published in Scrip
Executive Summary
Meiji Holdings, the diversified Japanese group formed on April 1st, is looking to raise sales in its pharmaceutical business to ¥145.0 billion ($1.50 billion) by April 2012.